Key result
Propranolol is a versatile nonselective beta-blocker that has been effectively used for over 50 years to manage a wide range of cardiovascular and noncardiovascular conditions.
Why the study?
The authors sought to recount the journey of propranolol from its inception to the present day across its numerous cardiovascular and noncardiovascular indications.
Design
Historical review
Authors
Loading...
Supports ongoing use given cost-effectiveness; leaves open modern comparative trials versus newer agents.
This historical review highlights the enduring clinical utility and cost-effectiveness of propranolol across a wide spectrum of cardiovascular and noncardiovascular indications 50 years after its discovery.
A. V. Srinivasan (2018) conducted a review in Cardiovascular and noncardiovascular conditions. Propranolol was evaluated. Propranolol is a versatile nonselective beta-blocker that has been effectively used for over 50 years to manage a wide range of cardiovascular and noncardiovascular conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: